You are currently on the new version of our website. Access the old version .
Thalassemia ReportsThalassemia Reports
  • Thalassemia Reports is published by MDPI from Volume 12 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Review
  • Open Access

29 September 2014

HbA2 Measurements in β-Thalassemia and in Other Conditions

,
,
and
1
Laboratorio di Genetica Umana, Settore Microcitemia, Ospedali Galliera, Genova, Italy
2
Medicina di Laboratorio, Ospedale di Treviso, Azienda U.L.S.S. N.9, Treviso, Italy
3
The Hemoglobinopathies Laboratory, Departments of Human and Clinical Genetics, Leiden University Medical Center, O&O Building, Einthovenweg 20, 2333 ZC Leiden, The Netherlands
*
Author to whom correspondence should be addressed.

Abstract

Quite a few papers have been written on the significance of elevated hemoglobin (Hb) A2 as a parameter for the diagnosis of β-thalassemia trait, on the cutoff values to be used in diagnostics and on the significance and effects of factors reducing or elevating the expression of HbA2 and last but not least on the need for reliable measurement methods and precise calibrations with accurate standards. However, little has been published on the causes that elevate or reduce the HbA2 levels in β- and a-thalassemia and in other conditions. For a better understanding of the value of a precise measurement of this parameter we summarize and elucidate in this review the direct and indirect mechanisms that cause the variations in HbA2 expression and that influence the value of this parameter in particular conditions. We conclude by explaining the advantages and disadvantages of trusting on a precise measurement in the complete diagnostic contest.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.